Implementing a Community-Led Arsenic Mitigation Intervention for Private Well Users in American Indian Communities: A Qualitative Evaluation of the Strong Heart Water Study Program.

RANAS model arsenic consolidated framework for implementation research (CFIR) drinking water process evaluation

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
02 02 2023
Historique:
received: 05 12 2022
revised: 22 01 2023
accepted: 25 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

Arsenic is a naturally occurring toxicant in groundwater, which increases cancer and cardiovascular disease risk. American Indian populations are disproportionately exposed to arsenic in drinking water. The Strong Heart Water Study (SHWS), through a community-centered approach for intervention development and implementation, delivered an arsenic mitigation program for private well users in American Indian communities. The SHWS program comprised community-led water arsenic testing, point-of-use arsenic filter installation, and a mobile health program to promote sustained filter use and maintenance (i.e., changing the filter cartridge). Half of enrolled households received additional in-person behavior change communication and videos. Our objectives for this study were to assess successes, barriers, and facilitators in the implementation, use, and maintenance of the program among implementers and recipients. We conducted 45 semi-structured interviews with implementers and SHWS program recipients. We analyzed barriers and facilitators using the Consolidated Framework for Implementation Research and the Risks, Attitudes, Norms, Abilities, and Self-regulation model. At the implementer level, facilitators included building rapport and trust between implementers and participating households. Barriers included the remoteness of households, coordinating with community plumbers for arsenic filter installation, and difficulty securing a local supplier for replacement filter cartridges. At the recipient level, facilitators included knowledge of the arsenic health risks, perceived effectiveness of the filter, and visual cues to promote habit formation. Barriers included attitudes towards water taste and temperature and inability to procure or install replacement filter cartridges. This study offers insights into the successes and challenges of implementing an arsenic mitigation program tailored to American Indian households, which can inform future programs in partnership with these and potentially similar affected communities. Our study suggests that building credibility and trust between implementers and participants is important for the success of arsenic mitigation programs.

Identifiants

pubmed: 36768048
pii: ijerph20032681
doi: 10.3390/ijerph20032681
pmc: PMC9915175
pii:
doi:

Substances chimiques

Arsenic N712M78A8G
Water Pollutants, Chemical 0
Drinking Water 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIEHS NIH HHS
ID : P42 ES033719
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES025135
Pays : United States

Références

Implement Sci. 2015 Apr 21;10:53
pubmed: 25895742
Annu Rev Public Health. 2017 Mar 20;38:1-22
pubmed: 28384085
BMC Public Health. 2022 Jan 15;22(1):106
pubmed: 35033048
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Risk Anal. 2006 Apr;26(2):353-68
pubmed: 16573626
J Environ Manage. 2010 Jun;91(6):1316-23
pubmed: 20207069
Environ Res. 2017 Jul;156:74-79
pubmed: 28334644
Environ Health Perspect. 2016 Jul;124(7):890-9
pubmed: 26587579
Health Educ Behav. 2017 Feb;44(1):92-102
pubmed: 27230268
Science. 2021 Oct 29;374(6567):eabe4943
pubmed: 34709911
Sci Total Environ. 2015 Feb 1;505:1361-9
pubmed: 24975493
Risk Anal. 2005 Dec;25(6):1531-43
pubmed: 16506980
J Diabetes Res. 2018 Sep 13;2018:2742565
pubmed: 30302343
Sci Total Environ. 2023 Mar 1;862:160217
pubmed: 36410482
Sci Total Environ. 2021 Sep 15;787:147555
pubmed: 33991916
Environ Pollut. 2021 Oct 15;287:117655
pubmed: 34426377
Sci Total Environ. 2006 Oct 1;369(1-3):42-50
pubmed: 16750243
Implement Sci. 2016 May 17;11:72
pubmed: 27189233
Sci Total Environ. 2008 Jan 25;389(2-3):245-52
pubmed: 17919687
Lancet Public Health. 2017 Nov;2(11):e513-e521
pubmed: 29250608
Health Promot Pract. 2005 Apr;6(2):134-47
pubmed: 15855283
Psychiatry Res. 2020 Jan;283:112376
pubmed: 31036287
Environ Res. 2019 Jan;168:41-47
pubmed: 30261340
Circulation. 2020 Jun 23;141(25):e948-e959
pubmed: 32460555
Sci Total Environ. 2015 Feb 1;505:1274-81
pubmed: 24875279
Public Health. 2019 Nov;176:98-105
pubmed: 30661805
Postgrad Med J. 2003 Jul;79(933):391-6
pubmed: 12897217
Environ Toxicol Pharmacol. 2015 Nov;40(3):828-46
pubmed: 26476885
Environ Res. 2019 Oct;177:108616
pubmed: 31442790
Br J Health Psychol. 2014 Nov;19(4):701-19
pubmed: 24112306
Arch Environ Contam Toxicol. 2001 Jan;40(1):1-9
pubmed: 11116335
Sci Total Environ. 2020 Oct 10;738:139683
pubmed: 32535281
Am Psychol. 2000 Oct;55(10):1166-7
pubmed: 11080850
Am J Epidemiol. 2012 Nov 15;176(10):865-74
pubmed: 23097256
Int J Hyg Environ Health. 2021 Jul;236:113792
pubmed: 34144357
Sci Total Environ. 2016 Aug 15;562:999-1009
pubmed: 27118151
Environ Sci Process Impacts. 2019 Mar 20;21(3):456-468
pubmed: 30714588
Sci Total Environ. 2019 Feb 10;650(Pt 2):3120-3133
pubmed: 30373089
Environ Health Perspect. 2009 Sep;117(9):1428-33
pubmed: 19750109
Int J Environ Health Res. 2012;22(5):431-49
pubmed: 22292899
Int J Hyg Environ Health. 2022 Mar;240:113919
pubmed: 35033992
PLoS One. 2022 Sep 9;17(9):e0274069
pubmed: 36083872
Int J Environ Res Public Health. 2019 Oct 22;16(20):
pubmed: 31652610
Appl Psychol Health Well Being. 2022 May;14(2):413-433
pubmed: 34668329
Arch Environ Occup Health. 2006 Jul-Aug;61(4):171-5
pubmed: 17867571
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Environ Health Perspect. 2021 Jun;129(6):65002
pubmed: 34132602
Environ Health Perspect. 2013 Mar;121(3):295-302
pubmed: 23458756

Auteurs

Darcy M Anderson (DM)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Annabelle Black Bear (AB)

Missouri Breaks Industries Research, Cheyenne River Sioux Tribe, Eagle Butte, SD 57625, USA.

Tracy Zacher (T)

Missouri Breaks Industries Research, Cheyenne River Sioux Tribe, Eagle Butte, SD 57625, USA.

Kelly Endres (K)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Ronald Saxton (R)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Francine Richards (F)

Missouri Breaks Industries Research, Cheyenne River Sioux Tribe, Eagle Butte, SD 57625, USA.

Lisa Bear Robe (LB)

Missouri Breaks Industries Research, Cheyenne River Sioux Tribe, Eagle Butte, SD 57625, USA.

David Harvey (D)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Indian Health Service, Rockville, MD 20857, USA.

Lyle G Best (LG)

Missouri Breaks Industries Research, Cheyenne River Sioux Tribe, Eagle Butte, SD 57625, USA.

Reno Red Cloud (RR)

Environmental Resource Department, Oglala Sioux Tribe, Pine Ridge, SD 57770, USA.

Elizabeth D Thomas (ED)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Joel Gittelsohn (J)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Marcia O'Leary (M)

Missouri Breaks Industries Research, Cheyenne River Sioux Tribe, Eagle Butte, SD 57625, USA.

Ana Navas-Acien (A)

Department of Environmental Health Science, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.

Christine Marie George (CM)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH